Why is the prostate cancer death rate declining in the United States?
about
Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?Recent advances in the histopathology and molecular biology of prostate cancer.Changes in pathologic outcomes and operative trends with robot-assisted laparoscopic radical prostatectomy.Racial and geographic disparities in late-stage prostate cancer diagnosis in Florida.Controversies regarding screening for prostate cancer.Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.PSA mass screening: is there enough evidence?Radical retropubic prostatectomy: a review of outcomes and side-effects.PSA screening and prostate cancer mortality.Does PSA screening reduce prostate cancer mortality?Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.Trends and characteristics in prostate cancer mortality in Japan.Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality.Is social support from family associated with PSA testing? An exploratory analysis using the Health Information National Trends Survey (HINTS) 2005.A randomised, wait-list controlled trial: evaluation of a cognitive-behavioural group intervention on psycho-sexual adjustment for men with localised prostate cancer.International trends in prostate-cancer mortality in the "PSA ERA".Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
P2860
Q30309318-FBB3ED7F-8241-4798-9C38-14EA350C6C7AQ33808366-F34D2D2D-FE8E-4180-93D9-F8B1880F99E3Q34453337-B13A56A2-802D-42DB-A455-EB37991272CBQ35111916-E7C2BFBB-4683-42B6-8313-332AB7036EF8Q36861719-18967FBE-5307-4CE3-BFB1-612B736C0D02Q37396566-389B9B92-A355-4826-B207-D523F6B58811Q37579100-2A0B7715-32E4-4FB9-9497-9AC7E1422C1CQ37878474-25780DAB-32B3-4FDA-BFA3-6111C711ECC6Q39525885-97FAFBE3-337E-4A13-8C08-B1D053AEE24FQ39525903-FBA18A20-3937-4CD1-9380-E6867B5C3DB2Q39693898-F720B07D-CB93-49CC-9DBB-319C3814D939Q44516073-DFDC0870-0C30-4381-8C8A-6C64DFCCDCC1Q46584324-DE3C8475-5A9F-4ACF-B3BE-AD679E7B5A75Q46981312-162762B8-3450-48A4-97DC-9761C8E18FB4Q48030884-935723AA-41FF-4B9E-9469-B5CB644294F3Q50674659-0A16A0CD-A44F-46B8-8267-5E5FB9CA9B5FQ52913260-97EC964F-23A6-4983-B345-65052B2DB308
P2860
Why is the prostate cancer death rate declining in the United States?
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Why is the prostate cancer death rate declining in the United States?
@en
Why is the prostate cancer death rate declining in the United States?
@nl
type
label
Why is the prostate cancer death rate declining in the United States?
@en
Why is the prostate cancer death rate declining in the United States?
@nl
prefLabel
Why is the prostate cancer death rate declining in the United States?
@en
Why is the prostate cancer death rate declining in the United States?
@nl
P2860
P1433
P1476
Why is the prostate cancer death rate declining in the United States?
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(19980115)82:2<249::AID-CNCR1>3.0.CO;2-M
P407
P577
1998-01-01T00:00:00Z